Chromic picolinate treatment
AssigneeNutrition 21
InventorsHerb Boynton, Gary W. Evans
Life of this patent
Estimating the term…
Abstract
The administration of chromic picolinate, preferably in the form of chromic tripicolinate, as a prophylactic or therapeutic agent for controlling various blood serum parameters. In particular, the administration is for controlling blood serum lipid levels, including the lowering of undesirably high blood serum LDL-cholesterol levels and the raising of blood serum HDL-cholesterol levels. Additionally, the administration is for controlling undesirable high blood serum glucose levels, this being particularly applicable for the treatment of maturity-onset diabetes. Additionally, chromic picolinate, preferably in the form of chromic tripicolinate, is administered to facilitate uptake of amino acids by skeletal muscle. Thus chromic picolinate can act as an effective anabolic agent.
Claims31
A method for treating undesirable high levels of blood serum lipids in an individual in need of such treatment, comprising the administration of an effective blood serum lipid-reducing amount of a composition consisting essentially of chromic tripicolinate.
A method for treating undesirable high levels of blood serum lipids in an individual in need of such treatment, comprising the administration of an effective, blood serum lipid reducing amount of chromic tripicolinate.
A method for treating undesirable high levels of blood serum lipids in an individual, comprising:
- a) evaluating the individual for undesirable high levels of blood serum lipids;
- and
- b) then, when the evaluation indicates undesirable high levels of blood serum lipids, administering an effective, blood serum lipid reducing dose of chromic tripicolinate.
A method for treating undesirable high levels of blood serum lipids in an individual, comprising:
- a) evaluating the individual for undesirable high levels of blood serum lipids;
- and
- b) then, when the evaluation indicates undesirable high levels of blood serum lipids, administering an effective blood serum reducing amount of chromium ion and picolinate ion such the two can form chromic tripicolinate in the individual.
A method for increasing blood serum levels of HDL-cholesterol in an individual in need thereof, comprising the administration of an effective amount of chromic tripicolinate.
A method for increasing an undesirable low level of blood serum HDL-cholesterol in an individual, comprising:
- a) evaluating the individual for the undesirable low level of blood serum HDL-cholesterol;
- and
- b) then, when the evaluation indicates an undesirable low level of blood serum HDL-cholesterol, administering an effective HDL-cholesterol increasing dose of chromic tripicolinate.
A method for lowering blood serum LDL-cholesterol in an individual in need of such reduction, comprising the administration, over a plurality of days, of chromic tripicolinate in a dose having at least about 10 micrograms of chromium per day.
A method for lowering blood serum LDL-cholesterol in an individual in need of such reduction, comprising:
- a) evaluating the individual's blood serum LDL-cholesterol level;
- and
- b) then administering, over a plurality of days, a composition consisting essentially of chromic tripicolinate in a dose having at least about 10 micrograms of chromium per day;
- c) then re-evaluating the individual's blood serum LDL-cholesterol level.
A method for lowering blood serum LDL-cholesterol in an individual in need of such reduction, comprising:
- a) evaluating the individual's blood serum LDL-cholesterol level;
- and
- b) then administering, over a plurality of days, a composition consisting essentially of a chromium ion containing compound and a picolinate containing compound, in a manner such that the two can form chromic tripicolinate in the individual, and in an amount sufficient such that a dose of chromic tripicolinate having at least about 10 micrograms of chromium per day is provided to the individual;
- c) then re-evaluating the individual's blood serum LDL-cholesterol.
A method for the prevention of undesirable high levels of blood serum lipids in a patient in need thereof, comprising the administration to said patient of substantially pure chromic tripicolinate in a dose having at least about 10 micrograms of chromium per day.
Dependencies are inferred from the claim text.